Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pope Research Corporation
With
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Completed 2 years in the FUNCTION (WA19926) trial
Patient has provided written informed consent and is willing to comply with the requirements of this study protocol
You may not be if
Requirement for immediate treatment with a biologic therapy following completion of the FUNCTION (WA19926) trial as per treating physician judgement.
Presence of any condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of RA
Clareo Health | The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience
